跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 14,006 条关于
“Ras pathway”
全部
14,006
临床试验
5,639
药物
577
机构
233
资讯
7,557
去年
FDA Approves Prescient Therapeutics' Phase 2 Trial of PTX-100 for Cutaneous T-Cell Lymphomas
去年
Vividion Therapeutics Initiates Phase I Trial of Novel RAS-PI3Kα Inhibitor for Advanced Solid Tumors
11个月前
Novel RAS-PI3K Inhibitor Enters Clinical Trials, Targeting Cancer Growth Without Metabolic Side Effects
9个月前
Revolution Medicines Receives FDA Breakthrough Therapy Designation for Daraxonrasib in KRAS G12-Mutant Pancreatic Cancer
2年前
Sysmex Inostics' RAS-RAF-SEQ Assay Gains New York Approval for Clinical Trial Use
9个月前
BBOT Presents First-in-Class RAS:PI3Kα Breaker BBO-10203 Data at SABCS, Launches Phase 1 Trial
上个月
BBOT Advances Triple KRAS-PI3Kα Pipeline with Dual Combination Dosing, Reports $344M Cash Runway into 2028
去年
Trametinib Shows Promise in Treating Severe Hypertrophic Cardiomyopathy in Children
2个月前
Adlai Nortye Advances First-in-Class Pan-RAS(ON) ADC AN4035 into Phase I Trial for RAS-Addicted Solid Tumors
3年前
Lorlatinib Shows Promise in ALK-Driven Refractory Neuroblastoma with Emerging Resistance Mechanisms Identified
第 1 页,共 756 页
上一页
下一页